Ko Ock Bae, Lee Dae Ho, Kim Sang We, Lee Jung Shin, Kim Shin, Huh Jooryung, Suh Cheolwon
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea.
Korean J Intern Med. 2009 Jun;24(2):128-34. doi: 10.3904/kjim.2009.24.2.128. Epub 2009 Jun 8.
BACKGROUND/AIMS: Although the incidence of T-cell non-Hodgkin's lymphoma (NHL) is higher in Far East Asia than in Western countries, its incidence and clinical course in Korea are not well-defined. Therefore, we assessed the relative frequency and clinical features of T-cell NHL in Korea.
We performed a retrospetcive analysis of 586 patients with NHL.
101 (17.2%) had T-cell NHL. The most frequent subtypes of T-cell NHL were extranodal NK/T-cell lymphoma, nasal type (NASAL), peripheral T-cell lymphoma, unspecified type (PTCL-U), and anaplastic large cell lymphoma, T/null cell, primary systemic type (ALCL). The seven pathological subtypes could be classified into three prognostic subgroups. When patients with the three most frequent subtypes were grouped together, their survival was reflected in the International Prognostic Index (IPI) scores. Univariate analysis of IPI elements and other clinical features showed that clinical stage and extranodal sites were significant predictors of survival. Cox multivariate analysis showed that the number of extranodal sites was the only independent prognostic indicator.
The relative frequency of T-cell NHL seems to be decreasing in Korea, although NASAL remains frequent. Korean patients with ALCL appear to have an unfavorable prognosis. Large-scale studies are warranted for Korean patients with T-cell NHL.
背景/目的:尽管东亚地区T细胞非霍奇金淋巴瘤(NHL)的发病率高于西方国家,但韩国的发病率及临床病程尚不明确。因此,我们评估了韩国T细胞NHL的相对发病率及临床特征。
我们对586例NHL患者进行了回顾性分析。
101例(17.2%)为T细胞NHL。T细胞NHL最常见的亚型为结外NK/T细胞淋巴瘤,鼻型(NASAL)、外周T细胞淋巴瘤,非特指型(PTCL-U)以及间变性大细胞淋巴瘤,T/null细胞,原发性全身型(ALCL)。这七种病理亚型可分为三个预后亚组。当将三种最常见亚型的患者归为一组时,其生存率反映在国际预后指数(IPI)评分中。对IPI因素及其他临床特征进行单因素分析显示,临床分期和结外部位是生存的重要预测因素。Cox多因素分析显示,结外部位数量是唯一的独立预后指标。
韩国T细胞NHL的相对发病率似乎在下降,尽管鼻型仍然常见。韩国ALCL患者的预后似乎不佳。有必要对韩国T细胞NHL患者进行大规模研究。